Here are three recent news updates on key gastroenterology and endoscopy companies.
Valeant Pharmaceuticals entered into a licensing agreement with Norgine for a bowel-cleansing oral solution used to prepare for colonoscopies.
EndoChoice reported total revenue for the second quarter of 2016 was $19.3 million, but net loss for the second quarter totaled $24.7 million.
EndoChoice's Lumos received FDA clearance and was recently launched in the United States.